Masseter and Thigh Muscle Ultrasound to Predict Dysphagia and Sarcopenia in Critically Ill Adults
Official title: Diagnostic Accuracy of Masseter and Rectus Femoris Muscle Ultrasound for the Diagnosis of Dysphagia and Sarcopenia in Critically Ill Patients
Run by Hospital General Universitario Gregorio Marañon · NCT07787312 · Data updated 2026-11-12
This study tests whether measuring the masseter muscle with ultrasound can help identify dysphagia in adults after critical illness and extubation, alongside evaluation of sarcopenia.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 323 (estimated) |
| Sponsor | Hospital General Universitario Gregorio Marañon Academic / other |
| Locations | 1 site (Madrid, Madrid) |
| Status | Recruiting |
| Started | February 3, 2026 |
| Main results expected | December 2027 |
| Study ends | August 2028 |
| Registry record updated | August 26, 2026 |
| Trial ID | NCT07787312 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who were critically ill and required prolonged invasive ventilation, either extubated recently or with a tracheostomy and meeting oral feeding criteria.
✕Probably not a fit
Patients with pre-existing dysphagia or those unable to undergo the assessment within 36 hours after extubation may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center observational study will examine the relationship between masseter and rectus femoris muscle thickness measured by ultrasound and the presence of post-extubation dysphagia and sarcopenia in critically ill adults. Dysphagia will be assessed with the MECVVm test, while ultrasound data will be analyzed for diagnostic accuracy and association with clinical outcomes. The goal is to determine whether bedside muscle ultrasound can provide objective information to identify patients at risk of dysphagia and sarcopenia after extubation or in tracheostomized patients. Eligible participants are adults who required invasive ventilation for more than 48 hours and are awake, extubated within 6-36 hours or tracheostomized and tolerating breathing without ventilation for at least 6 hours daily. Exclusion criteria include pre-existing dysphagia or inability to complete assessment within 36 hours post-extubation.
Why it matters
Potential benefit: If successful, this approach could offer a quick, non-invasive way to flag patients at higher risk of swallowing difficulties and muscle loss, guiding early interventions.
How similar studies have gone: Previous research suggests muscle ultrasound can reflect muscle mass changes, but diagnostic accuracy for predicting dysphagia in this specific setting is still being explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years. * Critically ill patients requiring invasive mechanical ventilation for \>48 hours. * Extubated patients: extubation 6-36 hours before study assessment. * Tracheostomized patients: surgical or percutaneous tracheostomy considered clinically suitable to initiate oral feeding, tolerating spontaneous breathing without mechanical ventilation for at least 6 hours/day, and negative cuff-leak test. * Awake and cooperative, with effective cough and ability to manage oral secretions. * Written informed consent obtained. Exclusion Criteria: * Documented pre-existing oropharyngeal dysphagia. * Inability to undergo study assessment within 36 hours after extubation. * In tracheostomized patients, positive cuff-leak test before study assessment.
Where it's running
-
Hospital General Universitario Gregorio Marañón
Madrid, Madrid, Spain Recruiting
Study contacts
- Study coordinator: Sara Casanova Prieto, Md
- Email: sara.casanova@salud.madrid.org
- Phone: +34665286063
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
How surgery for obstructive sleep apnea affects swallowing and oral function
This study compares swallowing and oral function before and after surgical treatment for OSA versus non-surgical care in adults with moderate-to-severe OSA.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
-
GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes
This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.
-
Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis
We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.